Sandi Lam to Helicobacter Infections
This is a "connection" page, showing publications Sandi Lam has written about Helicobacter Infections.
Connection Strength
0.885
-
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 2003 Mar 15; 17(6):799-805.
Score: 0.222
-
Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther. 2001 Dec; 15(12):1875-82.
Score: 0.203
-
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 2001 Dec; 15(12):1959-65.
Score: 0.203
-
Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study. Am J Gastroenterol. 2000 Sep; 95(9):2225-32.
Score: 0.186
-
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial. Aliment Pharmacol Ther. 2003 Oct 15; 18(8):829-36.
Score: 0.058
-
Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the disease. Aliment Pharmacol Ther. 2002 Dec; 16(12):2037-42.
Score: 0.014